propacetamol

06/01/2001 - "Analysis of pain intensity and pain relief scores demonstrated that propacetamol produced a significantly greater improvement in pain relief than saline from 45 min until 5 h after the injection. "
06/01/2001 - "The pain scores were significantly lower in the Propacetamol group measured at two intervals of the study, although visual analog scale pain intensity scores were smaller than 3 in both groups. "
06/01/2015 - "However, the recommendations regarding propacetamol doses for pain control are vague. "
06/01/2011 - "Both formulations are associated with few AEs, although patients receiving propacetamol have a higher incidence of pain on infusion."
06/01/2011 - "However, pain on infusion occurred more frequently in those receiving propacetamol compared with placebo (23% vs 1%). "

06/01/2015 - "Intravenous propacetamol has been shown to be effective for postoperative pain control. "
03/01/1998 - "Efficacy of propacetamol in the treatment of postoperative pain. "
01/01/1995 - "[Efficacy of propacetamol in postoperative pain based on two modes of intravenous administration]."
06/01/2015 - "Comparison of the efficacy and safety of different doses of propacetamol for postoperative pain control after breast surgery."
06/01/2003 - "The intensity change of postoperative pain was then evaluated 10 times with visual analog scale and verbal describing scale during 6 h from the beginning of propacetamol infusion. "

05/01/2006 - "In these 41 children with acute fever of infectious origin, a propacetamol dose of 25.5 (0.6) mg/kg IV had significantly greater antipyretic efficacy than placebo and was equally well tolerated. "
05/01/2006 - "This study compared the antipyretic efficacy and tolerability of IV propacetamol and placebo after a single administration in children with acute fever of infectious origin. "
01/01/2011 - "One published trial demonstrated acetaminophen injection is noninferior to propacetamol injection for fever related to infection in pediatric patients. "
01/01/2009 - "In a randomized, noninferiority study in paediatric patients with an infection-induced fever, intravenous paracetamol 15 mg/kg treatment was shown to be no less effective than propacetamol 30 mg/kg in terms of antipyretic efficacy. "
10/01/2008 - "To investigate the effect of intravenous propacetamol, a parenteral bioprecursor of acetaminophen, on systemic blood pressure in critically ill patients with fever, and to establish the prevalence and clinical significance of this effect. "

08/01/2007 - "A prospective, randomised, double-blind, clinical evaluation was performed to compare the efficacy of a single bolus injection of 40 mg parecoxib and 2 g propacetamol, administered twice within 12 h following surgical repair of inguinal hernia. "
08/01/2005 - "A single infusion of i.v. paracetamol 15 mg.kg(-1) produced analgesia similar to a single infusion of propacetamol 30 mg.kg(-1) following inguinal hernia repair in children. "
08/01/2005 - "A new intravenous (i.v.) formulation of paracetamol and propacetamol (prodrug of paracetamol) were compared to determine tolerance and relative analgesic efficacy during the first 6 h after inguinal hernia repair performed under general anesthesia combined with ilioinguinal block in children. "
05/01/2005 - "Within the first 12 h after inguinal hernia repair in adult patients, a single injection of parecoxib 40 mg compares favorably with 2 injections of propacetamol 2 g."
05/01/2005 - "A randomized, double-blind comparison between parecoxib sodium and propacetamol for parenteral postoperative analgesia after inguinal hernia repair in adult patients."

09/01/2014 - "Efficacy of intravenous propacetamol hydrochloride in the treatment of an acute attack of migraine."
09/01/2014 - "To compare the efficacy of a single intravenous administration of propacetamol, a prodrug of paracetamol (acetaminophen) with a single dose of oral rizatriptan in treating acute migraine attacks. "
09/01/2014 - "Propacetamol is either equivalent or superior in efficacy to rizatriptan for treating acute migraine attacks, while having the advantage of parenteral administration in patients whose migraines are accompanied by nausea and vomiting."